|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Departments of Radiology/Division of Pediatric Radiology (Dr. Blankenberg), Cardiothoracic Surgery (Drs. Robbins, Vriens, and Mr. Stoot), Pathology (Dr. Berry), and Radiology/Division of Nuclear Medicine (Dr. Strauss), Stanford University School of Medicine, Stanford, CA; and the Department of Laboratory Medicine (Dr. Tait), University of Washington, Seattle, WA.
Correspondence to: Francis G. Blankenberg, MD, Department of Radiology/Division of Pediatric Radiology, Stanford University School of Medicine, 300 Pasteur Dr, Stanford, CA 94305-5105; e-mail: MA.FRB{at}forsythe.stanford.edu
Study objectives: Early detection and treatment of lung transplant rejection is critical for preservation of pulmonary graft function. Damage to pulmonary allografts is mediated by apoptotic cell death induced by the alloreactive T lymphocytes that infiltrate lung grafts. Previous studies demonstrate that acute cardiac allograft rejection can be visualized using radiolabeled annexin V. This study was done to determine whether this technique could visualize acute rejection in a rodent model of unilateral orthotopic lung transplantation.
Design: Eighteen Sprague-Dawley ACI rats underwent removal of their left lung followed by orthotopic transplant of either an allogeneic (PVG, immunologically mismatched; N = 10) or a syngeneic (ACI, immunologically matched) pulmonary graft (N = 8). Animals were imaged 1 h after IV injection of 1 mCi (37.0 MBq) of 99mTc-annexin V 1 to 7 days after transplantation.
Results: Lungs receiving the allograft demonstrated moderate to marked mononuclear infiltration of the perivascular, interstitial, and peribronchial tissues. No mononuclear infiltrates were noted in the native right lungs nor in the syngeneic transplants. Region of interest image analysis revealed significant (p < 0.0005) increases of transplant to normal lung activity ratios 3 to 7 days after allograft surgery. The increased annexin V uptake in these lungs was confirmed at biodistribution assay (allograft 151% greater than isograft activity, p < 0.005).
Conclusions: Acute experimental lung transplant rejection can be noninvasively identified using 99mTc-annexin V. Radiolabeled annexin V may be a clinically useful noninvasive screening tool for acute rejection.
Key Words: acute rejection apoptosis lymphocytes organ transplantation pulmonary radionuclide imaging
This article has been cited by other articles:
![]() |
H. H. Boersma, B. L.J.H. Kietselaer, L. M.L. Stolk, A. Bennaghmouch, L. Hofstra, J. Narula, G. A.K. Heidendal, and C. P.M. Reutelingsperger Past, Present, and Future of Annexin A5: From Protein Discovery to Clinical Applications J. Nucl. Med., December 1, 2005; 46(12): 2035 - 2050. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takei, Y. Kuge, S. Zhao, M. Sato, H. W. Strauss, F. G. Blankenberg, J. F. Tait, and N. Tamaki Time Course of Apoptotic Tumor Response After a Single Dose of Chemotherapy: Comparison with 99mTc-Annexin V Uptake and Histologic Findings in an Experimental Model J. Nucl. Med., December 1, 2004; 45(12): 2083 - 2087. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Taki, T. Higuchi, A. Kawashima, J. F. Tait, S. Kinuya, A. Muramori, I. Matsunari, K. Nakajima, N. Tonami, and H. W. Strauss Detection of Cardiomyocyte Death in a Rat Model of Ischemia and Reperfusion Using 99mTc-Labeled Annexin V J. Nucl. Med., September 1, 2004; 45(9): 1536 - 1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Britz-Cunningham and S. J. Adelstein Molecular Targeting with Radionuclides: State of the Science J. Nucl. Med., December 1, 2003; 44(12): 1945 - 1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mochizuki, Y. Kuge, S. Zhao, E. Tsukamoto, M. Hosokawa, H. W. Strauss, F. G. Blankenberg, J. F. Tait, and N. Tamaki Detection of Apoptotic Tumor Response In Vivo After a Single Dose of Chemotherapy with 99mTc-Annexin V J. Nucl. Med., January 1, 2003; 44(1): 92 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Post, P. D. Katsikis, J. F. Tait, S. M. Geaghan, H. W. Strauss, and F. G. Blankenberg Imaging Cell Death with Radiolabeled Annexin V in an Experimental Model of Rheumatoid Arthritis J. Nucl. Med., October 1, 2002; 43(10): 1359 - 1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Belhocine, N. Steinmetz, R. Hustinx, P. Bartsch, G. Jerusalem, L. Seidel, P. Rigo, and A. Green Increased Uptake of the Apoptosis-imaging Agent 99mTc Recombinant Human Annexin V in Human Tumors after One Course of Chemotherapy as a Predictor of Tumor Response and Patient Prognosis Clin. Cancer Res., September 1, 2002; 8(9): 2766 - 2774. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Russell, J. A. O'Donoghue, R. Finn, J. Koziorowski, S. Ruan, J. L. Humm, and C. C. Ling Iodination of Annexin V for Imaging Apoptosis J. Nucl. Med., May 1, 2002; 43(5): 671 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Blankenberg, L. Naumovski, J. F. Tait, A. M. Post, and H. W. Strauss Imaging Cyclophosphamide-Induced Intramedullary Apoptosis in Rats Using 99mTc-Radiolabeled Annexin V J. Nucl. Med., February 1, 2001; 42(2): 309 - 316. [Abstract] [Full Text] |
||||
![]() |
C. H. Contag, S. Fraser, and R. Weissleder Strategies in In Vivo Molecular Imaging NeoReviews, December 1, 2000; 1(12): e225 - 232. [Full Text] |
||||
![]() |
H. D'Arceuil, W. Rhine, A. de Crespigny, M. Yenari, J. F. Tait, W. H. Strauss, T. Engelhorn, A. Kastrup, M. Moseley, F. G. Blankenberg, et al. 99mTc Annexin V Imaging of Neonatal Hypoxic Brain Injury Editorial Comment Stroke, November 1, 2000; 31(11): 2692 - 2700. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |